To be presented October 9, 2024

In this training session, participants will delve into the intricacies of patent and trademark issues related to the FDA regulatory process. On the trademark side, the session will cover how proposed trademarks are reviewed and evaluated by the FDA, emphasizing how the FDA evaluation criteria differ from those of the USPTO. On the patent side, the session will cover the interplay of exclusivity rights granted by the FDA and patent rights granted by the USPTO.

Attendees will learn strategies for seeking to protect patents and trademarks related to pharmaceuticals. This knowledge is essential for professionals involved in bringing new pharmaceutical products to market.

FL, GA, PA: Approved
DE, VA: Pending